Sat.Jan 06, 2024

article thumbnail

Derm In The News: December 31-January 6

Dermatology Times

Keep up with the latest headlines in dermatology from the past week, including a successful year for the Skin of Color Society, a rise in skin clinic visits attributed to carbon monoxide levels, and more.

Clinic 73
article thumbnail

Aspirin Inhibits Metastatic Cancer Spread, Reducing Mortality by 21 Percent: Study

Aesthetics Advisor

Aspirin is a long-established and widely used medication with a rich history. In addition to its well-known uses for pain relief and its anti-inflammatory and anticoagulant properties, a recent study indicates that cancer patients who take low-dose aspirin daily experience a 21 percent reduction in mortality. Furthermore, there is evidence of aspirin’s role in preventing cancer metastasis.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ChatGPT Can Provide Reliable Information on AD

The Dermatology Digest

Large language models like Chat-Generative Pre-Trained Transformer (ChatGPT) have become novel resources for patients, especially as physicians struggle to keep up with the unsustainable number of electronic messages and questions they get from their patients. It turns out that Chat-GPT may be a reliable resource and supplement to physician-dispensed advice on atopic dermatitis (AD), according to a research letter in the J ournal of the European Academy of Dermatology and Venereology.

Eczema 36
article thumbnail

IPC Adds to Board of Directors

The Dermatology Digest

André Vicente Esteves de Carvalho, MD, PhD, and Amy Paller, MS, MD, are the newest members of the International Psoriasis Council’s (IPC) volunteer Board of Directors. Dr. Carvalho is responsible for the Psoriasis Ambulatory and a researcher at the Hospital Moinhos de Vento Complexo in Porto Alegre, Brazil. Dr. Paller is the Walter J. Hamlin Professor and Chair of Dermatology, Professor of Pediatrics, and Principal Investigator of the NIH-funded Skin Biology and Diseases Resource-based Center at